- Home
- NYXH vs INNV Comparison
NYXH vs INNV Comparison
Compare NYXH & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- INNV
- Stock Information
- Founded
- NYXH 2009
- INNV 2007
- Country
- NYXH Belgium
- INNV United States
- Employees
- NYXH N/A
- INNV N/A
- Industry
- NYXH Medical/Dental Instruments
- INNV Medical/Nursing Services
- Sector
- NYXH Health Care
- INNV Health Care
- Exchange
- NYXH Nasdaq
- INNV Nasdaq
- Market Cap
- NYXH 394.1M
- INNV 439.5M
- IPO Year
- NYXH 2021
- INNV 2021
- Fundamental
- Price
- NYXH $6.50
- INNV $2.96
- Analyst Decision
- NYXH Strong Buy
- INNV Sell
- Analyst Count
- NYXH 4
- INNV 2
- Target Price
- NYXH $14.75
- INNV $5.00
- AVG Volume (30 Days)
- NYXH 86.3K
- INNV 66.7K
- Earning Date
- NYXH 05-13-2025
- INNV 05-06-2025
- Dividend Yield
- NYXH N/A
- INNV N/A
- EPS Growth
- NYXH N/A
- INNV N/A
- EPS
- NYXH N/A
- INNV N/A
- Revenue
- NYXH $4,680,609.00
- INNV $806,614,000.00
- Revenue This Year
- NYXH $504.18
- INNV $13.21
- Revenue Next Year
- NYXH $149.52
- INNV $10.29
- P/E Ratio
- NYXH N/A
- INNV N/A
- Revenue Growth
- NYXH 3.98
- INNV 11.91
- 52 Week Low
- NYXH $6.30
- INNV $2.90
- 52 Week High
- NYXH $13.50
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- NYXH 21.44
- INNV 34.24
- Support Level
- NYXH $10.26
- INNV $2.94
- Resistance Level
- NYXH $11.87
- INNV $3.59
- Average True Range (ATR)
- NYXH 0.75
- INNV 0.18
- MACD
- NYXH -0.48
- INNV -0.02
- Stochastic Oscillator
- NYXH 3.59
- INNV 8.70
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.